• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
New administrative data in Truveta Data and features in Truveta Studio help researchers accelerate scientifically rigorous research

New administrative data in Truveta Data and features in Truveta Studio help researchers accelerate scientifically rigorous research

by Michael Simonov, MD | Mar 26, 2025 | News

Today, we’re excited to celebrate our latest innovation in Truveta across both Truveta Data and Truveta Studio. Truveta Data has expanded to include new administrative data to enable more comprehensive analyses of healthcare outcomes and patient journeys. We...
Truveta Data grows to include linked closed claims for more than 200 million patients

Truveta Data grows to include linked closed claims for more than 200 million patients

by Truveta News | Feb 13, 2025 | Data

Truveta Data has now expanded to include new commercial, Medicare, and Medicaid closed claims on more than 200 million patients, linked with electronic health record (EHR) data for more than 120 million patients already part of Truveta Data. Truveta Data now provides...
Truveta Data now includes more than 120 million de-identified patients

Truveta Data now includes more than 120 million de-identified patients

by Truveta News | Nov 14, 2024 | News

Truveta Data, the most complete, timely, and clean electronic health record (EHR) data, now includes more than 120 million de-identified patients – more than one-third of the U.S. population – empowering researchers to study patients representative of the diversity of...

Share this


Recent posts

  • Truveta leads a new era in cancer research with the most complete, representative, and timely real-world data on all cancers
  • Top 5 takeaways from Truveta Symposium 2025
  • Women’s health: Pain medication remains rare for women receiving IUDs

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Get started

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Interested in learning more?

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice